Handbook of anticancer pharmacokinetics and pharmacodynamics
著者
書誌事項
Handbook of anticancer pharmacokinetics and pharmacodynamics
(Cancer drug discovery and development)
Humana Press, c2004
- : E-ISBN
大学図書館所蔵 全3件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
System requirements for accompanying disk: Adobe Acrobat reader 6.0 or later
Includes bibliographies and index
内容説明・目次
- 巻冊次
-
ISBN 9781588291776
内容説明
Leading investigators synthesize the entire laboratory and clinical process of developing anticancer drugs to create a single indispensable reference that covers all the steps from the identification of cancer-specific targets to phase III clinical trials. These expert authors provide their best guidance on a wide variety of issues, including clinical trial design, preclinical screening, and the development and validation of bioanalytic methods. The chapters on identifying agents to test in phase III trials and on trial design for the approval of new anticancer agents offer a unique roadmap for moving an agent to NDA submission.
目次
Molecular Targets Udai Banerji, Ian Judson, and Paul Workman Preclinical Screening for New Anticancer Agents Angelika M. Burger and Heinz-Herbert Fiebig Mouse Models in Cancer Drug Discovery and Development Edward A. Sausville and Melinda Hollingshead Defining the Starting Dose: Should It Be Based on mg/kg, mg/m2, or Fixed? Howard Gurney Phase I Trials in Oncology: Design and Endpoints James Cassidy Analytical Methods: Development, Validation, and Clinical Applicability Hans Ehrsson, Staffan Eksborg, and Jonas Bergh Validation and Control of Bioanalytical Methods in Clinical Drug Development H. Thomas Karnes Clinical Pharmacology Overview Andrew P. Beelen and Lionel D. Lewis Pharmacokinetic Modeling Sharyn D. Baker and Michelle A. Rudek Pharmacodynamic Modeling Kenneth S. Bauer and William P. Petros Pharmacometric Knowledge-Based Oncology Drug Development Paul J. Williams, James A. Uchizono, and Ene I. Ette Protein Binding of Anticancer Drugs Alex Sparreboom and Walter J. Loos Metabolism (Non-CYP Enzymes) Sally A. Coulthard and Alan V. Boddy Cytochrome P450 and Anticancer Drugs Yuichi Ando Polymorphisms in Genes of Drug Targets and Metabolism and in DNA Repair Jan Stoehlmacher, Syma Iqbal, and Heinz-Josef Lenz Drug Interactions, Laurent P. Rivory ABC Transporters: Involvement in Multidrug Resistance and Drug Disposition Susan E. Bates and Tito Fojo Intrathecal Chemotherapy Jeff Stone and Susan M. Blaney Use of Microdialysis in Preclinical and Clinical Development of Anticancer Agents William C. Zamboni Regional Therapy of Cancer Using Continuous Hyperthermic Peritoneal Perfusion or Vascular Isolation and Perfusion Techniques H. Richard Alexander, Maihgan A. Kavanagh, Steven K. Libutti, and James F. Pingpank Isolated Lung Perfusion for the Treatment of Inoperable Pulmonary Malignancies David S. Schrump Pharmacokinetics of Isolated Lung Perfusion with Antitumor Agents Suoping Zhai Central Nervous System Malignancy and Clinical Pharmacology Steve Y. Cho and Howard A. Fine Pharmacokinetics of Anticancer Drugs in Children Lisa C. Iacono, P. Kellie Turner, and Clinton F. Stewart Clinical Pharmacokinetics in the Elderly Patricia W. Slattum and Jurgen Venitz The Combination of Angiogenesis Inhibitors and Radiotherapy for the Treatment of Primary Tumors Kevin Camphausen and Cynthia Menard Gene Therapy for the Treatment of Cancer H. Trent Spencer and Jacques Galipeau Vaccines for the Treatment of Cancer Philip M. Arlen, James Gulley, Lauretta Odogwu, and John L. Marshall Pharmacokinetics of Antibodies and Immunotoxins in Mice and Humans Victor Ghetie, E. Sally Ward, and Ellen S. Vitetta Pharmacokinetics of Biologicals Hakan Mellstedt, Jan-Erik Frodin, and Anders Osterborg Exposure-Response Relationship of Anticancer Agents: A Clinical Pharmacology and Biopharmaceutics Regulatory Perspective Atiqur Rahman Identifying Agents to Test in Phase III Trials Thomas G. Roberts Jr., Thomas J. Lynch Jr., and Bruce A. Chabner Clinical Trial Designs for Approval of New Anticancer Agents: A Clinical Science Daniel D. Von Hoff Pharmacogenetic Counseling Jill M. Kolesar Index
- 巻冊次
-
: E-ISBN ISBN 9781592597345
内容説明
Leading investigators synthesize the entire laboratory and clinical process of developing anticancer drugs to create a single indispensable reference that covers all the steps from the identification of cancer-specific targets to phase III clinical trials. These expert authors provide their best guidance on a wide variety of issues, including clinical trial design, preclinical screening, and the development and validation of bioanalytic methods. The chapters on identifying agents to test in phase III trials and on trial design for the approval of new anticancer agents offer a unique roadmap for moving an agent to NDA submission.
目次
- 1 Molecular Targets Udai Banerji, Ian Judson and Paul Workman
- 2 Preclinical Screening for New Anticancer Agents Angelika M. Burger and Heinz-Herbert Fiebig
- 3 Mouse Models in Cancer Drug Discovery and Development Edward A. Sausville and Melinda Hollingshead
- 4 Defining the starting dose: Should it be based on mg/kg, mg/m2, or fixed? Howard Gurney
- 5 Phase I Trials in Oncology: Design and Endpoints James Cassidy
- 6 Analytical Methods: Development, Validation and Clinical Applicability Hans Ehrsson, Staffan Eksborg and Jonas Bergh
- 7 Validation and Control of Bioanalytical Methods in Clinical Drug Development H. Thomas Karnes
- 8 Clinical Pharmacology Overview Andrew P. Beelen and Lionel D. Lewis
- 9 Pharmacokinetic Modeling Sharyn D. Baker and Michelle A. Rudek
- 10 Pharmacodynamic Modeling Kenneth S. Bauer and William P. Petros
- 11 Pharmacometric Knowledge-Based Oncology Drug Development Paul J. Williams, James Uchizono and Ene I. Ette
- 12 Protein Binding of Anticancer Drugs Alex Sparreboom and Walter J. Loos
- 13 Metabolism (Non-CYP Enzymes) Sally A. Coulthard and Alan V. Boddy
- 14 Cytochrome P450 and anticancer drugs Yuichi Ando
- 15 Polymorphisms in genes of drug targets and metabolism and in DNA Repair Jan Stoehlmacher, Syma Iqbal and Heinz-Josef Lenz
- 16 Drug Interactions Laurent P. Rivory
- 17 ABC Transporters: Involvement in Multidrug Resistance and Drug Disposition Susan E. Bates and Tito Fojo
- 18 Intrathecal Chemotherapy Jeff Stone and Susan M. Blaney
- 19 Use of Microdialysis in Preclinical and Clinical Development of Anticancer Agents William C. Zamboni
- 20 Regional Therapy of Cancer Using Continuous Hyperthermic Peritoneal Perfusion or Vascular Isolation and Perfusion Techniques H. Richard Alexander, Maihgan A. Kavanagh, Steven K. Libutti, and James F. Pingpank
- 21 Isolated Lung Perfusion for the Treatment of Inoperable Pulmonary Malignancies David S. Schrump
- 22 Pharmacokinetics of Isolated Lung Perfusion with Antitumor Agents Suoping Zhal
- 23 Central Nervous System Malignancy and Clinical Pharmacology Howard A. Fine and Steve Y. Cho
- 24 Pharmacokinetics of Anticancer Drugs in Children Lisa C. Iacono, P. Kellie Turner, and Clinton F. Stewart
- 25 Clinical Pharmacokinetics in the Elderly Patricia W. Slattum and Jurgen Venitz
- 26 The Combination of Angiogenesis Inhibitors and Radiotherapy for the Treatment of Primary Tumors Kevin Camphausen and Cynthia Menard
- 27 Gene Therapy for the Treatment of Cancer H. Trent Spencer and Jacques Galipeau
- 28 Vaccines for the Treatment of Cancer Lauretta Odogwu, James Gulley, Philip M. Arlen, and John L. Marshall
- 29 Pharmacokinetics of Antibodies and Immunotoxins in Mice and Humans Victor Ghetie, E. Sally Ward, and Ellen S. Vitetta
- 30 Pharmacokinetics of Biologicals Hakan Mellstedt, Jan-Erik Frodin, and Anders Osterborg
- 31 Eposure-Response Relationship of Anticancer Agents: Perspectives from an FDA Clinical Pharmacology and Biopharmaceutics Reviewer Atiqur Rahman and Brian P. Booth
- 32 Identifying Agents to Test in Phase III Trials Thomas G. Roberts Jr., Thomas J. Lynch Jr., and Bruce A. Chabner
「Nielsen BookData」 より